Welcome!

News Feed Item

The Bonnie J. Addario Lung Cancer Foundation Honors Leading Lung Cancer Oncologist with the 2014 Addario Lectureship Award

Roy S. Herbst M.D., Ph.D. honored at the 15th International Lung Cancer Congress

SAN CARLOS, Calif., Aug. 1, 2014 /PRNewswire-USNewswire/ -- The Bonnie J. Addario Lung Cancer Foundation (ALCF) will honor Roy S. Herbst, Ensign Professor of Medicine and Chief of Medical Oncology at Yale Cancer Center, with the 2014 Addario Lectureship Award for his continued leadership and expertise in lung cancer treatment and research. Dr. Herbst of Yale Cancer Center will receive the award at the 15th International Lung Cancer Congress being held on July 31Aug. 2 in Huntington Beach, California.

The Bonnie J. Addario Lung Cancer Foundation to Honor Roy Herbst, M.D., Ph.D. with the 2014 Addario Lectureship Award at the 15th International Lung Cancer Congress on August 1 in Huntington Beach, California.

"Dr. Herbst's contribution and dedication to lung cancer treatment and research is truly remarkable and we are thrilled to present him with the Addario Lectureship Award this year," said Bonnie J. Addario, lung cancer survivor and founder of the ALCF.

Each year the ALCF recognizes one special leader who is making great strides to eradicate lung cancer and fight for the lives affected by this disease. According to the American Cancer Society, more than 228,000 people in the United States will be diagnosed this year with lung cancer, and nearly 160,000 lung cancer patients will die – a fact that cannot go unnoticed.

Dr. Herbst is internationally recognized for his work developing personalized therapy for the treatment of non-small cell lung cancer– namely the process of linking genetic abnormalities of cancer cells to novel therapies. In 2011, Dr. Herbst co-led a groundbreaking trial at the University of Texas MD Anderson Cancer Center called BATTLE-1 (Biomarker-based Approaches of Targeted Therapy for Lung Cancer Elimination). This trial was one of the first to use fresh tissue and adaptive randomization to identify the best drug to treat patients for refractory non-small cell lung cancer (NSCLC). In the beginning of 2012, Dr. Herbst became the co-principal investigator of a second trial, BATTLE-2, which focuses on targeting KRAS genes. The trial is currently open at the University of Texas MD Anderson Cancer Center in Houston, Texas and Yale Cancer Center in New Haven, Connecticut.  

These trials led to the development of the Lung Cancer Master Protocol (Lung-MAP), a first-of-its-kind clinical trial that uses a multi-drug, targeted screening approach to match patients with promising new treatments based on their unique tumor profiles. The clinical trial is for patients with advanced squamous cell lung cancer. Dr. Herbst is co-chair of the Lung-MAP oversight committee and chair of the drug selection committee.  

"The stagnant 16 percent five-year survival rate for lung cancer must change," Addario said. "And Dr. Herbst is one of the brilliant minds leading the charge."

Dr. Herbst is a member of the American Association for Cancer Research (AACR), where he chairs the Tobacco Task Force, as well as the American Society of Clinical Oncology and the Institute of Medicine's National Cancer Policy Forum. He is a fellow of the American College of Physicians. He is also a vice chair of the Southwest Oncology Group's lung committee, a member of the medical advisory committee for the Lung Cancer Research Foundation and chair of the communications committee for the International Association for the Study of Lung Cancer. He has authored more than 200 peer-reviewed papers and has current grant funding for his work from numerous sources including the National Cancer Institute, AACR and multiple charitable foundations.

Past Addario Lectureship Award recipients include:

  • 2013 Recipient: Tony Mok, M.D., Professor in the Department of Clinical Oncology at the Chinese University of Hong Kong in Prince of Wales Hospital in Hong Kong
  • 2012 Recipient: D. Ross Camidge, M.D., Ph.D., Director of the Thoracic Oncology Clinical Program and Associate Director for Clinical Research, Colorado University Cancer Center
  • 2011 Recipient: William Pao, M.D., Ph.D., Associate Professor of Medicine, Ingram Associate Professor of Cancer Research, Director, Personalized Cancer Medicine, Vanderbilt Ingram Cancer Center
  • 2010 Recipient: David R. Gandara, M.D., Associate Director, Clinical Research, UC Davis Cancer Center
  • 2009 Recipient: Harvey Pass, M.D., B.A., Director of the Division of Thoracic Surgery and Chief of Thoracic Surgery, New York University Medical Center
  • 2008 Recipient: Paul A. Bunn, Jr. M.D., Principal Investigator and Director, University of Colorado Cancer Center

The ALCF has supported the Lung Cancer Congress for the past seven years and serves as a co-sponsor along with the IASLC. The annual three-day event provides physicians with practical information regarding the clinical implications of lung cancer screening, the latest clinical data impacting the treatment of lung cancer, and novel agents and strategies that are changing the future of lung cancer therapy.

"We are proud of our continued partnership with the International Lung Cancer Congress because it provides a place for people to listen and think differently about how to treat lung cancer," Addario said. "And more importantly, they value the patient in that process."

About the Bonnie J. Addario Lung Cancer Foundation
The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation works with a diverse group of physicians, organizations, industry partners, individuals, survivors, and their families to identify solutions and make timely and meaningful change. The ALCF was established on March 1, 2006 as a 501c(3) non-profit organization and has raised more than $10 million for lung cancer research.

Bonnie J. Addario Lung Cancer Foundation logo

Photo - http://photos.prnewswire.com/prnh/20140730/130935
Logo - http://photos.prnewswire.com/prnh/20140730/132466

SOURCE Bonnie J. Addario Lung Cancer Foundation

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Evatronix will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Evatronix SA offers comprehensive solutions in the design and implementation of electronic systems, in CAD / CAM deployment, and also is a designer and manufacturer of advanced 3D scanners for professional applications.
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone inn...
As many know, the first generation of Cloud Management Platform (CMP) solutions were designed for managing virtual infrastructure (IaaS) and traditional applications. But that's no longer enough to satisfy evolving and complex business requirements. In his session at 21st Cloud Expo, Scott Davis, Embotics CTO, explored how next-generation CMPs ensure organizations can manage cloud-native and microservice-based application architectures, while also facilitating agile DevOps methodology. He expla...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
DevOps promotes continuous improvement through a culture of collaboration. But in real terms, how do you: Integrate activities across diverse teams and services? Make objective decisions with system-wide visibility? Use feedback loops to enable learning and improvement? With technology insights and real-world examples, in his general session at @DevOpsSummit, at 21st Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, explored how leading organizations use data-driven DevOps to close th...
Digital Transformation (DX) is not a "one-size-fits all" strategy. Each organization needs to develop its own unique, long-term DX plan. It must do so by realizing that we now live in a data-driven age, and that technologies such as Cloud Computing, Big Data, the IoT, Cognitive Computing, and Blockchain are only tools. In her general session at 21st Cloud Expo, Rebecca Wanta explained how the strategy must focus on DX and include a commitment from top management to create great IT jobs, monitor ...
"WineSOFT is a software company making proxy server software, which is widely used in the telecommunication industry or the content delivery networks or e-commerce," explained Jonathan Ahn, COO of WineSOFT, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service. However, the benefit of WebRTC for IoT is not only its convenience and interopera...
In a recent survey, Sumo Logic surveyed 1,500 customers who employ cloud services such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP). According to the survey, a quarter of the respondents have already deployed Docker containers and nearly as many (23 percent) are employing the AWS Lambda serverless computing framework. It’s clear: serverless is here to stay. The adoption does come with some needed changes, within both application development and operations. Tha...
Product connectivity goes hand and hand these days with increased use of personal data. New IoT devices are becoming more personalized than ever before. In his session at 22nd Cloud Expo | DXWorld Expo, Nicolas Fierro, CEO of MIMIR Blockchain Solutions, will discuss how in order to protect your data and privacy, IoT applications need to embrace Blockchain technology for a new level of product security never before seen - or needed.
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...